CDC Report Suggests Use of Antidote Could Have Prevented Opioid Overdose Deaths
Naloxone hydrochloride reverses the potentially fatal respiratory depression caused by opioid overdose and has been used increasingly since 1996. In October 2010, the Harm Reduction Coalition emailed a survey to the 50 programs known to distribute naloxone. From 1996-June 2010, programs reported providing training and distributing naloxone to an estimated 53,032 people and received reports of 10,171 overdose reversals using naloxone. Twenty-one (43.7 percent) programs reported problems obtaining naloxone in the "past few months" before the survey.
Related Articles on Pain Management:
USA Pain Professionals Opens in New Mexico
Three-Quarters of Healthcare Facilities Report Success Treating Chronic Pain With Integrative Medicine
Senate Committee Hears Testimony on Pain in America
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- Patient identification complexity & why the industry is still trying to get it right: 5 considerations
- The Center for Musculoskeletal Disorders installs Mazor system in ambulatory outpatient setting: 4 things to know
- 5 financial thoughts for mid-career physicians
- ASA, ePreop partner on quality reporting software: 5 notes
- RIVANNA partners with Vertec Scientific to market new anesthesia device: 3 notes